半夏泻心汤治疗幽门螺杆菌阳性相关性胃炎98例临床研究  

Clinical Study on 98 Cases of Banxiaxiexin Decoction for H. pylori-related Positive Gastritis

作　　者：曲智威[1] 于明俊[1] 刘春雷[1] 

机构地区：[1]北华大学附属医院,吉林吉林132011

出　　处：《北华大学学报（自然科学版）》2017年第3期368-370,共3页Journal of Beihua University（Natural Science）

基　　金：吉林省教育厅科学技术研究项目(2014502)

摘　　要：目的探讨半夏泻心汤治疗幽门螺杆菌阳性相关性胃炎临床疗效.方法慢性胃炎患者98例,随机分为两组,治疗组51例,给予半夏泻心汤治疗,对照组47例,给予胃苏颗粒治疗.结果治疗组临床症状总有效率达88.2%,对照组87.2%,治疗组较对照组有改善,但差异无统计学意义(P>0.0 5);治疗前治疗组的Hp感染率为62.7%,治疗后Hp清除率为80.1%,治疗前后比较差异具有统计学意义(P<0.05),对照组治疗前后比较差异无统计学意义(P>0.05),治疗组Hp清除率明显高于对照组(P<0.01).结论中药半夏泻心汤是一种有效的治疗慢性胃炎方剂,特别是治疗幽门螺杆菌阳性相关性胃炎疗效显著,值得临床推广使用.Objective To explore the clinical treatment of H. pylori positive gastritis with Banxiaxiexin Decoction. Method 98 cases of chronic gastritis were randomly divided into two groups, 51 cases for Banxiaxiexin Decoction group as a treatment group and 47 cases for Weisu Granules as a control group. Results The total effective rate of patients in the treatment group was 88.2% and that in the control group was 87.2% ,showing no significant difference（P〉0. 05 ）;the HP infection rate in the treatment group before the treatment was 62.7% and the HP clearance rate after treatment was 80.1%, with significant difference before and after the treatment （P〈 0.05 ）, while there was no significant difference before and after treatment in the control group （ P〉0.05 ）, indicating that the HP clearance in the treatment group was obviously higher than that in control group （P〈0.01）. Conclusion Banxiaxiexin Decoction is an effective prescription in the treatment of chronic gastritis,especially gastritis associated with H. pylori infection, worthy to be popularized in the clinical practice.

关 键 词：半夏泻心汤 幽门螺杆菌阳性相关性胃炎 中药治疗 

分 类 号：R243[医药卫生—中医临床基础]